Debevoise Advises CD&R and TPG Capital in Their Acquisition of Covetrus At an Enterprise Value of Approximately $4 Billion

25 May 2022

Debevoise & Plimpton LLP is advising Clayton, Dubilier & Rice (CD&R) and TPG Capital in their acquisition of all outstanding shares of Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, representing an enterprise value of approximately $4 billion. For more information, please see the company’s press release.

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes.

The Debevoise team is led by M&A partners Paul Bird, Andrew Bab and Spencer Gilbert and includes associates Erik Andren, Richard Hughes, Susie Kim and Adrian St. Francis and law clerk Mafe Coelho, finance partners Jeffrey Ross and Scott Selinger and associates Alena Thomas and Hanson Yu and law clerk Kristen Scully, benefits partner Jonathan Lewis and associate Jonathan Mangel, tax partner Peter Furci and associates Jay Evans and Samuel Krawiecz, capital markets partner Nicholas Pellicani and associate Amy Aixi Zhang, intellectual property partner Henry Lebowitz and associates Melody Godbolt and Moses Kim, antitrust partner Timothy McIver, counsel Kyra Bromley and associate Anne-Mette Heemsoth, FDA regulatory partner Paul Rubin, investment management partner Jason Auerbach and counsel Paul Laszlo, environmental counsel Stuart Hammer and associate Harry Zirlin, and litigation partner Mark Goodman, counsel Erich Grosz and Jacob Stahl and associate Samuel Rosh.